Mandate

Vinge advises UBS in connection with base prospectus regarding certificates and warrants

August 28, 2013

Vinge has advised UBS Deutschland AG in connection with the preparation of a three part base prospectus for structured products which will consist of various types of certificates and warrants. The structured products will primarily be traded on NASDAQ OMX Stockholm and possibly other Nordic exchanges. The base prospectus was approved by the Swedish Financial Supervisory Authority on 16 August 2013.

Vinge’s team consisted of responsible partner Anders Strid and lawyer Yohanna Öhrnegård.

Related

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of their production facility in Uppsala to Ofichem. The Uppsala site specializes in small-scale, early-phase development work.
August 13, 2025

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025